Vascular Biogenics Ltd.
Patents, Design & Utilities
Last updated:
List of all Vascular Biogenics Ltd. patents 14 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS OF ANTI-TUMOR THERAPY Filling date: 26 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: METHODS OF ANTI-TUMOR THERAPY Filling date: 26 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 28 Apr 2022 |
Grant | Utility: Treatment methods using adenovirus Filling date: 26 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Methods of inducing responsiveness to anti-angiogenic agent Filling date: 26 Sep 2025 Issue date: 7 Dec 2021 |
Application | Utility: DIAGNOSTIC METHODS FOR ANTI-ANGIOGENIC AGENT THERAPY Filling date: 26 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND CANCER Filling date: 26 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND INFLAMMATION Filling date: 26 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR TUMOR RADIOSENSITIZATION Filling date: 26 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: BISPECIFIC ANTIBODIES TO MOSPD2 AND T CELL- OR NK CELL-SPECIFIC MOLECULES Filling date: 26 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: METHODS OF INDUCING RESPONSIVENESS TO ANTI-ANGIOGENIC AGENT Filling date: 26 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: Oxidized lipids and methods of use thereof Filling date: 26 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Methods of inducing responsiveness to anti-angiogenic agent Filling date: 26 Sep 2025 Issue date: 20 Aug 2019 |
Grant | Utility: Compositions and methods for treating glioblastoma GBM Filling date: 26 Sep 2025 Issue date: 6 Aug 2019 |
Showing 1 to 14 of 14 patents.